A detailed history of Syon Capital LLC transactions in Argenx Se stock. As of the latest transaction made, Syon Capital LLC holds 860 shares of ARGX stock, worth $540,355. This represents 0.04% of its overall portfolio holdings.

Number of Shares
860
Previous 835 2.99%
Holding current value
$540,355
Previous $359 Million 29.83%
% of portfolio
0.04%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$434.22 - $551.9 $10,855 - $13,797
25 Added 2.99%
860 $466 Million
Q2 2024

Aug 13, 2024

SELL
$356.01 - $451.55 $1,780 - $2,257
-5 Reduced 0.6%
835 $359 Million
Q1 2024

May 14, 2024

SELL
$356.95 - $413.29 $58,539 - $67,779
-164 Reduced 16.33%
840 $331 Million
Q4 2023

Feb 02, 2024

BUY
$338.91 - $506.01 $1,016 - $1,518
3 Added 0.3%
1,004 $382 Million
Q3 2023

Nov 03, 2023

BUY
$369.35 - $548.43 $369,719 - $548,978
1,001 New
1,001 $492 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Syon Capital LLC Portfolio

Follow Syon Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syon Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syon Capital LLC with notifications on news.